Please see below to view the coverage details for this session entry.

Wednesday, October 24


A View From the Other Side: Where are Pharmaceutical Companies Spending Time and Money?

Large pharmaceutical companies play two integral, yet different, roles in drug development.    Through collaborations with leading academic institutions, pharmaceutical companies can provide funding for translational research and ultimately license break-through technology. Emerging biotech companies enter into strategic partnerships with larger pharmaceutical companies to fund product development.  These partnerships provide an alternative to the higher cost of capital associated with venture financing while continuing to lower overall project risk.  Come learn about the latest trends, and how to best position your technology for a potential collaboration with Pharma.


Wednesday October 24, 2012 1:25pm - 2:10pm
San Antonio (9721 Arboretum Boulevard, Austin, TX 78759)

Jeff Bockman, PhD

Vice President, Defined Health

James Cassidy, MBChB, MD, MSc, FRCP (Glas, Edin), FRSE

Head of Oncology Early Research and Development, Roche

Jamey Skillings, MD

Vice President, Global Medical Affairs, Pfizer